JP2023500574A5 - - Google Patents
Info
- Publication number
- JP2023500574A5 JP2023500574A5 JP2022520769A JP2022520769A JP2023500574A5 JP 2023500574 A5 JP2023500574 A5 JP 2023500574A5 JP 2022520769 A JP2022520769 A JP 2022520769A JP 2022520769 A JP2022520769 A JP 2022520769A JP 2023500574 A5 JP2023500574 A5 JP 2023500574A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962925115P | 2019-10-23 | 2019-10-23 | |
| US62/925,115 | 2019-10-23 | ||
| PCT/US2020/056908 WO2021081239A1 (en) | 2019-10-23 | 2020-10-22 | T-cell modulatory chimeric molecules and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023500574A JP2023500574A (ja) | 2023-01-10 |
| JP2023500574A5 true JP2023500574A5 (https=) | 2023-10-25 |
| JPWO2021081239A5 JPWO2021081239A5 (https=) | 2023-10-25 |
Family
ID=75620861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520769A Pending JP2023500574A (ja) | 2019-10-23 | 2020-10-22 | Ｔ細胞調節性キメラ分子及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230055644A1 (https=) |
| EP (1) | EP4048689A4 (https=) |
| JP (1) | JP2023500574A (https=) |
| CN (1) | CN114599674A (https=) |
| AU (1) | AU2020370292A1 (https=) |
| CA (1) | CA3146917A1 (https=) |
| IL (1) | IL290298A (https=) |
| WO (1) | WO2021081239A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3019005A1 (en) * | 2016-05-18 | 2017-11-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN116970059A (zh) | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| TW201920249A (zh) | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
| WO2019139896A1 (en) | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| AU2019401183A1 (en) * | 2018-12-19 | 2021-08-12 | Cue Biopharma, Inc. | Multimeric T-cell modulatory polypeptides and methods of use thereof |
| TW202208395A (zh) | 2020-05-12 | 2022-03-01 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| EP4211149A4 (en) | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| CN119095882A (zh) * | 2022-04-07 | 2024-12-06 | Cue生物制药股份有限公司 | 免疫细胞结合多肽 |
| GB202205771D0 (en) * | 2022-04-20 | 2022-06-01 | Replay Holdings Llc | Methods and compositions for cellular therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2010107199A (ru) * | 2007-07-31 | 2011-09-10 | Дзе Джонс Хопкинс Юниверсити (Us) | Конъюгат полипептид-нуклеиновая кислота для иммунопрофилактики или иммунотерапии для неопластических или инфекционных нарушений |
| EP3593812A3 (en) * | 2014-03-15 | 2020-05-27 | Novartis AG | Treatment of cancer using chimeric antigen receptor |
| PL3157552T3 (pl) * | 2014-06-18 | 2020-05-18 | Albert Einstein College Of Medicine | Polipeptydy syntac i ich zastosowania |
| CN116970059A (zh) * | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| IL269000B2 (en) * | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| TW201920249A (zh) * | 2017-09-07 | 2019-06-01 | 美商信號生物製藥公司 | 具有結合位點之t細胞調節多聚體多肽及其使用方法 |
-
2020
- 2020-10-22 WO PCT/US2020/056908 patent/WO2021081239A1/en not_active Ceased
- 2020-10-22 AU AU2020370292A patent/AU2020370292A1/en active Pending
- 2020-10-22 JP JP2022520769A patent/JP2023500574A/ja active Pending
- 2020-10-22 CA CA3146917A patent/CA3146917A1/en active Pending
- 2020-10-22 CN CN202080064663.3A patent/CN114599674A/zh not_active Withdrawn
- 2020-10-22 EP EP20878131.0A patent/EP4048689A4/en not_active Withdrawn
-
2022
- 2022-02-02 IL IL290298A patent/IL290298A/en unknown
- 2022-02-23 US US17/678,748 patent/US20230055644A1/en not_active Abandoned
-
2025
- 2025-09-12 US US19/327,171 patent/US20260070959A1/en active Pending